Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts

Transplantation

Volumn 70, Issue 1, 2000, Pages 15-21

  Cozzi, Emanuele ^a,b,d   Bhatti, Farah ^a   Schmoeckel, Michael ^a   Chavez, Gilda ^a   Smith, Kenneth G C ^b   Zaidi, Afzal ^a   Bradley, John R ^b   Thiru, Sathia ^b   Goddard, Martin ^c   Vial, Conrad ^a   Ostlie, Daniel ^a   Wallwork, John ^c   White, David J G ^a,b   Friend, Peter J ^b  

^a Imutran Ltd   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

^d Imutran Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; FEMALE; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; MALE; MONKEY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; XENOGRAFT;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD55; FEMALE; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; SURVIVORS; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034661964     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Auchincloss H Jr, Sachs DH. Xenogeneic transplantation. Annu Rev Immunol 1998; 16: 433.
2. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
3. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
4. Bach FH, Blakely ML, Van Der Werf M, et al. Discordant xenografting: a working model of problems and issues. Xenotransplantation 1993; 1: 8.
5. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998; 2: 695.
6. Paradis K, Langford G, Long Z, et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285(5431): 1236.
7. Platt JL. Hyperacute xenograft rejection. Austin, TX, RG Landes, 1995.
8. Galili U. Interaction of the natural anti-Gal antibody with alpha-galactosyl epitopes: a major obstacle for xenotransplantation on humans. Immunol Today 1993; 14: 480.
9. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Antipig IgM antibodies in human serum react predominantly with Gal(α1-3)Gal epitopes. Proc Natl Acad Sci USA 1993; 90: 11391.
10. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM III, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
11. Hancock WW. The past, present, and future of renal xenotransplantation. Kidney Int 1997; 51: 932.
12. Leventhal JR, Dalmasso AP, Cromwell JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993; 55: 857.
13. Rollins SA, Matis LA, Springhorn JP, Setter E, Wolff DW. Monoclonal antibodies directed against human C5 and C8 block complement-mediated damage of xenogeneic cells and organs. Transplantation 1995; 60: 1284.
14. Kobayashi T, Neethling FA, Koren E, et al. In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model. Transplant Proc 1996; 28: 604.
15. Pruitt SK, Bollinger RR, Collins BH, et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. Transplantation 1997; 63: 900.
16. Cooper DK, Human PA, Lexer G, et al. Effects of cyclosporine and antibody adsorption on pig cardiac xenograft survival in the baboon. J Heart Transplant 1988; 7: 238.
17. Alexandre G, Gianello P, Latinne D, et al. Plasmapheresis and splenectomy in experimental renal xenotransplantation. In: Hardy MA, ed. Xenograft 25. New York: Elsevier, 1989; 259.
18. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1: 964.
19. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91: 11153.
20. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995; 1: 423.
21. Cozzi E, Yannoutsos N, Langford GA, Pino-Chavez G, Wallwork J, White DJG. Effect of transgenic expression of human decay-accelerating factor on the inhibition of hyperacute rejection of pig organs. In: Cooper DKC, Kemp E, Platt JL, White DJ, eds. Xenotransplantation. The transplantation of organs and tissues between species, 2nd ed. Berlin: Springer-Verlag, 1997; 665.
22. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
23. Platt JL, Lin SS, McGregor CGA. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
24. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
25. Lambrigts D, Sachs DH, Cooper DKC. Discordant organ xenotransplantation in primates. Transplantation 1998; 66: 547.
26. Cozzi E, Tucker AW, Langford GA, et al. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 1997; 64: 1383.
27. Hopkins RF 3rd, Witmer TJ, Neubauer RH, Rabin H. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay. J Infect Dis 1982; 146: 734.
28. Wagoner LE, Taylor DO, Olsen SL, et al. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review. Clin Transplant 1996; 10: 437.
29. Tanabe K, Takahashi K, Sonda K, et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 1998; 65: 224.
30. Taniguchi S, Neethling FA, Korchagina EY, et al. In vivo immunoadsorption of antipig antibodies in baboons using a specific Gal(alpha)1-3Gal column. Transplantation 1996; 62: 1379.
31. Kobayashi T, Taniguchi S, Neethling FA, et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
32. Kozlowski T, Monroy R, Xu Y, et al. Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction. Transplantation 1998; 66: 176.
33. Fukushima N, Bouchart F, Gundry SR, et al. The role of anti-pig antibody in pig-to-baboon cardiac xenotransplant rejection. Transplantation 1994; 57: 923.
34. Feichtinger H, Su-Ling Li, Kaaya E, et al. A monkey model for Epstein Barr virus-associated lymphomagenesis in Human Acquired Immunodeficiency Syndrome. J Exp Med 1992; 176: 281.
35. Reitz BA, Bieber CP, Pennock JL. Cyclosporin A and lymphoma in non-human primates. In: White DJG, ed. Cyclosporin A. Amsterdam: Elsevier, 1982; 317.
36. Ierino FL, Kozlowski T, Siegel JB, et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439.
37. Cowan P, Goodman D, Aminian A, et al. Disseminated intravascular coagulation in non-immunosuppressed baboons receiving transgenic pig renal xenografts [Abstr 0185]. 5th Congress of the International Xenotransplantation Association, Nagoya, 1999.
38. Imai M, Kaczmarek E, Koziak K, et al. Suppression of ATP Diphosphohydrolase/CD39 in human vascular endothelial cells. Biochemistry 1999; 38: 13473.
39. Robson SC, Schulte am Esch J 2nd, Bach FH. Factors in xenograft rejection. Ann N Y Acad Sci 1999; 875: 261.